Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ronald W Gottschalk, MD
Galderma R&D
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ats Clinical Research
Santa Monica, California, United States
- Dadeland Dermatology
Coral Gables, Florida, United States
- Melissa L. F. Knuckles M.D., P.S.C.
Corbin, Kentucky, United States
- Dermatology Specialists Research
Louisville, Kentucky, United States
- Melissa L. F. Knuckles M.D., P.S.C.
Richmond, Kentucky, United States
- the Maryland Laser, Skin, and Vein Institute, Llc
Hunt Valley, Maryland, United States
- Grekin Skin Institute
Warren, Michigan, United States
- Hilary Baldwin
Brooklyn, New York, United States
- the Center for Dermatology at Linden Oaks
Rochester, New York, United States
- Brodell Medical, Inc.
Warren, Ohio, United States
- Center for Dermatology and Laser Surgery
Portland, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2011
- Primary completion
- 30 Jun 2013
- Completion
- 30 Jun 2013
- Last update posted
- 1 Aug 2022
- Registered enrollment
- 235
- Registry id
- NCT01426269
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.